Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
about
Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysisProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic AnalysisCost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studiesCost-effectiveness analysis of prostate cancer screening.Financial toxicity: a potential side effect of prostate cancer treatment among Australian men.
P2860
Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current and projected annual d ...... ing prostate-specific antigen.
@ast
Current and projected annual d ...... ing prostate-specific antigen.
@en
Current and projected annual d ...... ing prostate-specific antigen.
@nl
type
label
Current and projected annual d ...... ing prostate-specific antigen.
@ast
Current and projected annual d ...... ing prostate-specific antigen.
@en
Current and projected annual d ...... ing prostate-specific antigen.
@nl
prefLabel
Current and projected annual d ...... ing prostate-specific antigen.
@ast
Current and projected annual d ...... ing prostate-specific antigen.
@en
Current and projected annual d ...... ing prostate-specific antigen.
@nl
P2093
P2860
P1476
Current and projected annual d ...... ing prostate-specific antigen.
@en
P2093
P2860
P407
P577
1999-01-01T00:00:00Z